Pharmaceutical - Mundipharma

Filter

Current filters:

Mundipharma

Popular Filters

Exclusive: Changing pharma marketplace means new dynamics to deal with, says Mundipharma executive

11-02-2014

The pharmaceutical market is changing, says Georg Toufar, chief marketing officer of Mundipharma International,…

InterviewsManagementMarkets & MarketingMundipharmaPharmaceutical

Skyepharma launches Flutiform in France for asthma

10-02-2014

UK drug delivery specialist Skyepharma has received regulatory approval and agreement on pricing reimbursement…

FlutiformFranceMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

Mundipharma strengthens patent rights for heroin substitution in deal with Phoenux

20-01-2014

Privately-held drugmaker Mundipharma International has acquired exclusive global rights to a family of…

MorphineMundipharmaNaloxoneNeurologicalPatentsPharmaceuticalPhoenux

Helsinn and Mundipharma collaborate on netupitant-palonosetron for China

Helsinn and Mundipharma collaborate on netupitant-palonosetron for China

23-12-2013

Privately-held Swiss drugmakers Helsinn and Mundipharma have signed a new, exclusive license and distribution…

Asia-PacificChinaHelsinnLicensingMundipharmanetupitantOncologypalonosetronPharmaceutical

Horizon Pharma and Mundipharma in deal for Lodotra in Middle East and Africa

11-11-2013

USA-based Horizon Pharma has signed an exclusive agreement with privately-held Swiss drugmaker Mundipharma…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingLodotraMundipharmaPharmaceuticalRest of the World

Flutiform trial for COPD initiated in Europe

Flutiform trial for COPD initiated in Europe

19-09-2013

UK drug delivery specialist Skyepharma (LSE: SKP) and privately-held Swiss drugmaker Mundipharma, which…

FlutiformMundipharmaPharmaceuticalResearchRespiratory and PulmonarySkyepharma

Mundipharma's bendamustine plus rituximab doubles PFS in non-Hodgkin lymphoma and MCL patients

20-02-2013

Results from the StiL NHL-1 study published in the Lancet today (February 20) show that a first-line…

bendamustineLevactMundipharmaOncologyPharmaceuticalResearchTeva Pharmaceutical IndustriesTreanda

SkyePharma/Mundipharma's Flutiform launched in Germany

23-09-2012

UK-based drug delivery specialist SkyePharma (LSE: SKP) last Friday announced the launch of Flutiform,…

EuropeFlutiformMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

EMA recommendations to deal with sterility concerns for DepoCyte

27-08-2012

The European Medicines Agency last Friday agreed a number of precautionary measures to deal with manufacturing…

DepoCyteEuropeMundipharmaOncologyPacira PharmaceuticalsPharmaceuticalRegulationSigma Tau

Flutiform receives UK regulatory approval; solid financials from SkyePharma

24-08-2012

UK-based drug delivery specialist SkyePharma (LSE: SKP) yesterday announced that the UK the Medicines…

FinancialFlutiformMundipharmaPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Infinity regains global rights to PI3K, FAAH; equity investment by Purdue

20-07-2012

USA-based Infinity Pharmaceuticals (Nasdaq: INFI) says it has restructured its strategic alliance with…

FinancialInfinity PharmaceuticalsLicensingMundipharmaPharmaceuticalPurdue PharmaResearch

European approval for Mundipharma/SkyePharma's asthma drug Flutiform

04-07-2012

After some delays, the European Commission has now adopted a legally binding decision in favor of granting…

EuropeFlutiformMundipharmaPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Infinity plunges as it halts two saridegib trials

19-06-2012

US drug discovery firm Infinity Pharmaceuticals (Nasdaq: INFI) saw its shares plummet 20% to $11 in pre-marketing…

Infinity PharmaceuticalsIPI-145MundipharmaOncologyPharmaceuticalResearchretaspimycinsaridegib

Company Spotlight

ImmunoGen

ImmunoGen

Back to top